Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1982 Oct 30;285(6350):1226–1227. doi: 10.1136/bmj.285.6350.1226

Graft-versus-host disease.

A M Denman
PMCID: PMC1499779  PMID: 6812816

Full text

PDF
1226

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Filipovich A. H., McGlave P. B., Ramsay N. K., Goldstein G., Warkentin P. I., Kesey J. H. Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation. Lancet. 1982 Jun 5;1(8284):1266–1269. doi: 10.1016/s0140-6736(82)92840-9. [DOI] [PubMed] [Google Scholar]
  2. Friedrich W., O'Reilly R. J., Koziner B., Gebhard D. F., Jr, Good R. A., Evans R. L. T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. Blood. 1982 Apr;59(4):696–701. [PubMed] [Google Scholar]
  3. Hersman J., Meyers J. D., Thomas E. D., Buckner C. D., Clift R. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med. 1982 Feb;96(2):149–152. doi: 10.7326/0003-4819-96-2-149. [DOI] [PubMed] [Google Scholar]
  4. Keating A., Singer J. W., Killen P. D., Striker G. E., Salo A. C., Sanders J., Thomas E. D., Thorning D., Fialkow P. J. Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature. 1982 Jul 15;298(5871):280–283. doi: 10.1038/298280a0. [DOI] [PubMed] [Google Scholar]
  5. Pahwa S. G., Pahwa R. N., Friedrich W., O'Reilly R. J., Good R. A. Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2663–2667. doi: 10.1073/pnas.79.8.2663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Powles R. L., Clink H. M., Spence D., Morgenstern G., Watson J. G., Selby P. J., Woods M., Barrett A., Jameson B., Sloane J. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet. 1980 Feb 16;1(8164):327–329. doi: 10.1016/s0140-6736(80)90881-8. [DOI] [PubMed] [Google Scholar]
  7. Prentice H. G., Blacklock H. A., Janossy G., Bradstock K. F., Skeggs D., Goldstein G., Hoffbrand A. V. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet. 1982 Mar 27;1(8274):700–703. doi: 10.1016/s0140-6736(82)92619-8. [DOI] [PubMed] [Google Scholar]
  8. Ramsay N. K., Kersey J. H., Robison L. L., McGlave P. B., Woods W. G., Krivit W., Kim T. H., Goldman A. I., Nesbit M. E., Jr A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med. 1982 Feb 18;306(7):392–397. doi: 10.1056/NEJM198202183060703. [DOI] [PubMed] [Google Scholar]
  9. Ritz J., Sallan S. E., Bast R. C., Jr, Lipton J. M., Clavell L. A., Feeney M., Hercend T., Nathan D. G., Schlossman S. F. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet. 1982 Jul 10;2(8289):60–63. doi: 10.1016/s0140-6736(82)91686-5. [DOI] [PubMed] [Google Scholar]
  10. Storb R. Decrease in the graft rejection rate and improvement in survival after marrow transplantation for severe aplastic anemia. Transplant Proc. 1979 Mar;11(1):196–198. [PubMed] [Google Scholar]
  11. Thomas E. D., Buckner C. D., Banaji M., Clift R. A., Fefer A., Flournoy N., Goodell B. W., Hickman R. O., Lerner K. G., Neiman P. E. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977 Apr;49(4):511–533. [PubMed] [Google Scholar]
  12. Thomas E. D., Buckner C. D., Sanders J. E., Papayannopoulou T., Borgna-Pignatti C., De Stefano P., Sullivan K. M., Clift R. A., Storb R. Marrow transplantation for thalassaemia. Lancet. 1982 Jul 31;2(8292):227–229. doi: 10.1016/s0140-6736(82)90319-1. [DOI] [PubMed] [Google Scholar]
  13. Thomas E. D., Storb R., Clift R. A., Fefer A., Johnson L., Neiman P. E., Lerner K. G., Glucksberg H., Buckner C. D. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975 Apr 24;292(17):895–902. doi: 10.1056/NEJM197504242921706. [DOI] [PubMed] [Google Scholar]
  14. Townsend T. R., Bolyard E. A., Yolken R. H., Beschorner W. E., Bishop C. A., Burns W. H., Santos G. W., Saral R. Outbreak of Coxsackie A1 gastroenteritis: a complication of bone-marrow transplantation. Lancet. 1982 Apr 10;1(8276):820–823. doi: 10.1016/s0140-6736(82)91872-4. [DOI] [PubMed] [Google Scholar]
  15. Vallera D. A., Youle R. J., Neville D. M., Jr, Kersey J. H. Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin. J Exp Med. 1982 Mar 1;155(3):949–954. doi: 10.1084/jem.155.3.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wade J. C., Newton B., McLaren C., Flournoy N., Keeney R. E., Meyers J. D. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med. 1982 Mar;96(3):265–269. doi: 10.7326/0003-4819-96-3-265. [DOI] [PubMed] [Google Scholar]
  17. Weiden P. L., Sullivan K. M., Flournoy N., Storb R., Thomas E. D. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med. 1981 Jun 18;304(25):1529–1533. doi: 10.1056/NEJM198106183042507. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES